Mandi L. Klamerus - Concepedia

Author

Mandi L. Klamerus

University of Michigan ORCID

Also Known As

M.L. Klamerus, Mandi Klamerus, Mandi L Klamerus, Mandi L. Klamerus

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

University of Michigan VA Center for Clinical Management Research VA Ann Arbor Healthcare System Kaiser Permanente Duke Medical Center

About

Mandi L. Klamerus is an author at University of Michigan specializing in medicine, health policy, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	244
2	Diabetes	3	3	189
3	Public Health	2	2	48
4	Health Sciences	1	1	34
5	Community Health Sciences	1	1	11

Mandi L. Klamerus

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The Role of Clinical Uncertainty in Treatment Decisions for Diabetic Patients with Uncontrolled Blood Pressure Eve A. Kerr, Brian J. Zikmund‐Fisher, Mandi L. Klamerus, Annals of Internal Medicine	2008	173
Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus Jeremy B. Sussman, Eve A. Kerr, Sameer D. Saini, JAMA Internal Medicine	2015	158
Case management for patients with poorly controlled diabetes: a randomized trial Sarah L. Krein, Mandi L. Klamerus, Sandeep Vijan, The American Journal of Medicine Family MedicineDisease ManagementDiabetes ManagementHealth PolicyCase Management	2004	141
Improving Blood Pressure Control Through a Clinical Pharmacist Outreach Program in Patients With Diabetes Mellitus in 2 High-Performing Health Systems Michele Heisler, Timothy P. Hofer, Julie A. Schmittdiel, Circulation	2012	128
Perceived Barriers to Implementing Individual Choosing Wisely® Recommendations in Two National Surveys of Primary Care Providers Brian J. Zikmund‐Fisher, Jeffrey T. Kullgren, Angela Fagerlin, Journal of General Internal Medicine	2016	123
Factors associated with persistent poorly controlled diabetes mellitus: Clues to improving management in patients with resistant poor control Matthew J. Crowley, Rob Holleman, Mandi L. Klamerus, Chronic Illness	2014	66
Comparison of Payment Changes and Choosing Wisely Recommendations for Use of Low-Value Laboratory Tests in the United States and Canada James Henderson, Zachary Bouck, Rob Holleman, JAMA Internal Medicine	2020	55
The Impact of Insurance on Access to Cancer Clinical Trials at a Comprehensive Cancer Center Justin F. Klamerus, Suanna S. Bruinooge, Xiaobu Ye, Clinical Cancer Research	2010	42
Type 2 Diabetes Management, Control and Outcomes During the COVID-19 Pandemic in Older US Veterans: an Observational Study Carole E. Aubert, James Henderson, Eve A. Kerr, Journal of General Internal Medicine Diabetes ManagementPreventive MedicineDiabetes EpidemiologyHealth PolicyGeriatrics	2022	37
Study protocol: The Adherence and Intensification of Medications (AIM) study - a cluster randomized controlled effectiveness study Michele Heisler, Timothy P. Hofer, Mandi L. Klamerus, Trials	2010	35

Page 1